Biome Australia Ltd
ASX:BIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Biome Australia Ltd
Selling, General & Administrative
Biome Australia Ltd
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Selling, General & Administrative
-AU$11m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Holista CollTech Ltd
ASX:HCT
|
Selling, General & Administrative
-AU$2.1m
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
0%
|
|
|
Bioxyne Ltd
ASX:BXN
|
Selling, General & Administrative
-AU$11.3m
|
CAGR 3-Years
-124%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
-32%
|
|
|
S
|
Skin Elements Ltd
ASX:SKN
|
Selling, General & Administrative
-AU$1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
McPherson's Ltd
ASX:MCP
|
Selling, General & Administrative
-AU$60.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Selling, General & Administrative
-AU$5.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Biome Australia Ltd
Glance View
Biome Australia Ltd. engages in the development and marketing of live biotherapeutics and complementary medicines. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-11-30. The firm licenses, develops and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). The company markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products include 22 products marketed under three brands, being Activated Probiotics, Activated Nutrients and Activated X Performance. These products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The company offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trials.
See Also
What is Biome Australia Ltd's Selling, General & Administrative?
Selling, General & Administrative
-11m
AUD
Based on the financial report for Jun 30, 2025, Biome Australia Ltd's Selling, General & Administrative amounts to -11m AUD.
What is Biome Australia Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-31%
Over the last year, the Selling, General & Administrative growth was -15%. The average annual Selling, General & Administrative growth rates for Biome Australia Ltd have been -19% over the past three years , -31% over the past five years .
